34911-25-6

Basic information

• Product Name: 7-CHLORO-1-INDANONE
• Synonyms: 7-CHLORO-1-INDANONE;7-CHLORO-INDAN-1-ONE;7-chloro-2,3-dihydroinden-1-one;7-chloro-2,3-dihydro-1H-inden-1-one;REF DUPL: 7-Chloro-1-indanone;1H-Inden-1-one, 7-chloro-2,3-dihydro-
• CAS NO: 34911-25-6
• Molecular Formula: C₉H₇ClO
• Molecular Weight: 166.6
• Product Categories: Indane/Indanone and Derivatives
• Mol File: 34911-25-6.mol
• Article Data: 9

Chemical Properties

• Melting Point: 98 °C
• Boiling Point: 288.2 °C at 760 mmHg
• Flash Point: 129.3 °C
• Appearance: /
• Density: 1.312 g/cm³
• Vapor Pressure: 0.00237mmHg at 25°C
• Refractive Index: 1.6
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 7-CHLORO-1-INDANONE(CAS DataBase Reference)
• NIST Chemistry Reference: 7-CHLORO-1-INDANONE(34911-25-6)
• EPA Substance Registry System: 7-CHLORO-1-INDANONE(34911-25-6)

Safety Data

• Hazard Codes: Xn
• Statements: 36/37/38-22
• Safety Statements: 26-36/37/39
• Hazardous Substances Data: 34911-25-6(Hazardous Substances Data)

Usage

Uses

7-Chloro-1-indanone is a reagent used to synthesize tetracyclic quinoline and quinoxaline carboxamides which are used as therapeutic topoisomerase inhibitors.

InChI:InChI=1/C9H7ClO/c10-7-3-1-2-6-4-5-8(11)9(6)7/h1-3H,4-5H2

Upstream product

• 609-65-4 o-chlorobenzoyl chloride 
• 2142-68-9 1-(2-chlorophenyl)ethanone 
• 74-85-1 ethene 
• 118-91-2 ortho-chlorobenzoic acid 
• 860356-79-2 7-chloro-4-nitro-indan-1-one 
• 861308-97-6 2-chloro-6-chloromethyl-benzonitrile 
• 6575-09-3 2-chloro-6-methyl-benzonitrile 
• 56043-01-7 2-amino-6-methylbenzonitrile 
• 1885-76-3 2-cyano-3-nitrotoluene 
• 1829-60-3 dimethyl 7-oxabicyclo[2.2.1]hepta-2,5-diene-2,3-dicarboxylate 
• 91131-19-0 3-(dimethylamino)-1-(2-chlorophenyl)propan-1-one 
• 77802-37-0 N-(2,3-dihydro-1H-inden-4-yl)acetamide 
• 32202-61-2 4-aminoindan 
• 58161-36-7 N-(3-oxo-2,3-dihydro-1H-inden-4-yl)acetamide 

Relevant articles and documents

-

-

CARBAMATE DERIVATIVE COMPOUNDS, PROCESSES FOR PREPARING THEM AND THEIR USES

The present invention relates to a pharmaceutical composition for treating or preventing CNS disorders containing a carbamate derivative compound and/or pharmaceutically acceptable salt thereof as an active ingredient. Furthermore, the present invention relates to a method for treatment or prevention CNS disorders comprising administering a carbamate derivative compound in a pharmaceutically effective amount to a subject in need of treatment or prevention of CNS disorders.

SUBSTITUTED FLUOROETHYL UREAS AS ALPHA 2 ADRENERGIC AGENTS

Therapeutic compounds, and methods, compositions, and medicaments related thereto are disclosed herein.